4.7 Article

Accurate identification of SARS-CoV-2 variant delta using graphene/CRISPR-dCas9 electrochemical biosensor

Journal

TALANTA
Volume 249, Issue -, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.talanta.2022.123687

Keywords

SARS-CoV-2; Variantdelta; CRISPR-dCas9; Accurateidentification; Electrochemicalbiosensor

Funding

  1. National Natural Science Foundation of China [22174024, 21974028, 22174022, 22127806]
  2. Shanghai Scientific and Technological Innovation Action Plan [19441915600]
  3. Shanghai Agricultural Development project [2021-02-08-00-12-F00772]
  4. China National Post-doctoral Program for Innovative Talents [BX20200090]
  5. China Post-doctoral Science Foundation [2021M700806]
  6. Shanghai Post-doctoral Excellence Program [2020066]

Ask authors/readers for more resources

A highly selective and sensitive detection method has been developed to accurately identify the SARS-CoV-2 Delta variant. The assay has the advantages of rapidity, high sensitivity, good reproducibility, and the ability to differentiate between different SARS-CoV-2 variants, which has been validated in clinical samples.
Delta (B.1.617.2), a highly infectious variant of SARS-CoV-2, has been sweeping the world, and threatening the safety of human life seriously. It is urgent to develop a highly selective and sensitive assay to accurately identify the SARS-CoV-2 variant Delta. In this work, we constructed a graphene/CRISPR-dCas9 electrochemical biosensor to accurately identify SARS-CoV-2 variant Delta, where the signal was further amplified by embedded electro-chemical probe [Ru(phen)2dppz]BF4. This detection assay could be finished within 47 min totally, with the detection limit of 1.2 pM and good reproducibility with a C.V.% of 2.48% (n = 5). And the biosensor could selectively identify Delta among SARS-CoV-2 and other variants, including Alpha, Beta, Gamma. This assay was further validated by 26 real clinical samples, showing 100% clinical sensitivity and 100% clinical specificity, which provides a new direction for identifying other SARS-CoV-2 variants in the future.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available